Targeted Delivery Leverage Eos Biosciences’ Eosome platform for partnering opportunities in precision therapeutics, focusing on agents that require targeted intracellular delivery to improve efficacy and safety profiles.

Strategic Partnerships Position collaboration with Cedars-Sinai-developed technology as a differentiator to attract biotech partners seeking innovative drug delivery platforms for oncology and rare diseases.

Pipeline Enablement Offer platform-enabled development services to accelerate preclinical and clinical program timelines by providing ready-to-use targeting and delivery capabilities for both approved and novel therapeutics.

Small Team Advantage Highlight agility and fast decision cycles of a lean team to attract partners seeking nimble collaborations and rapid pilots, complemented by a strong scientific foundation.

Funding Readiness Emphasize low revenue base as an opportunity for co-development, milestone-driven partnerships, and potential grant- and funding-aligned collaborations to de-risk early-stage programs.